Biogen Inc, Cambridge, MA, USA.
Dewpoint Therapeutics, Boston, MA, USA.
Nat Commun. 2024 Feb 26;15(1):1755. doi: 10.1038/s41467-024-45774-2.
Nearly two hundred common-variant depression risk loci have been identified by genome-wide association studies (GWAS). However, the impact of rare coding variants on depression remains poorly understood. Here, we present whole-exome sequencing analyses of depression with seven different definitions based on survey, questionnaire, and electronic health records in 320,356 UK Biobank participants. We showed that the burden of rare damaging coding variants in loss-of-function intolerant genes is significantly associated with risk of depression with various definitions. We compared the rare and common genetic architecture across depression definitions by genetic correlation and showed different genetic relationships between definitions across common and rare variants. In addition, we demonstrated that the effects of rare damaging coding variant burden and polygenic risk score on depression risk are additive. The gene set burden analyses revealed overlapping rare genetic variant components with developmental disorder, autism, and schizophrenia. Our study provides insights into the contribution of rare coding variants, separately and in conjunction with common variants, on depression with various definitions and their genetic relationships with neurodevelopmental disorders.
通过全基因组关联研究(GWAS)已经确定了近 200 个常见的变异抑郁症风险基因座。然而,罕见编码变异对抑郁症的影响仍知之甚少。在这里,我们在 320356 名英国生物库参与者中,根据调查、问卷和电子健康记录,对基于七种不同定义的抑郁症进行了全外显子组测序分析。我们表明,失活不耐受基因中罕见的破坏性编码变异的负担与各种定义的抑郁症风险显著相关。我们通过遗传相关性比较了不同抑郁症定义之间的罕见和常见遗传结构,并在常见和罕见变异体之间显示了不同的定义之间的遗传关系。此外,我们证明了罕见破坏性编码变异负担和多基因风险评分对抑郁症风险的影响是累加的。基因集负担分析揭示了与发育障碍、自闭症和精神分裂症重叠的罕见遗传变异成分。我们的研究为不同定义的抑郁症以及与神经发育障碍的遗传关系提供了罕见编码变异分别和共同作用的见解。